Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Immunome Inc shares valued at $999,996 were purchased by SIEGALL CLAY B on Oct 02 ’23. At $5.91 per share, SIEGALL CLAY B acquired 169,204 shares. The insider’s holdings grew to 319,636 shares worth approximately $8.16 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Turner Bruce purchased 42,300 shares, netting a total of over 249,993 in proceeds. Following the buying of shares at $5.91 each, the insider now holds 42,300 shares.
As published in their initiating research note from Leerink Partners on January 29, 2024, Immunome Inc [IMNM] has been an Outperform and the price target has been revised to $30. Analysts at Wedbush started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid December. As of October 29, 2021, Cantor Fitzgerald has initiated its “an Overweight” rating for IMNM.
Analyzing IMNM Stock Performance
During the last five days, there has been a surge of approximately 5.80%. Over the course of the year, Immunome Inc shares have jumped approximately 138.50%. Shares of the company reached a 52-week high of $30.96 on 03/07/24 and a 52-week low of $10.38 on 01/02/24. A 50-day SMA is recorded $21.85, while a 200-day SMA reached $11.41. Nevertheless, trading volume fell to 0.77 million shares from 0.42 million shares the previous day.
Support And Resistance Levels for Immunome Inc (IMNM)
According to the 24-hour chart, there is a support level at 24.80, which, if violated, would cause prices to drop to 24.08. In the upper region, resistance lies at 26.47. The next price resistance is at 27.42. RSI (Relative Strength Index) is 59.01 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.91, which suggests the price will decrease in the coming days. Percent R is at 40.55%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Immunome Inc subject to short interest?
Stocks of Immunome Inc saw a sharp steep in short interest on Feb 29, 2024 dropping by -0.76 million shares to 2.65 million. Data from Yahoo Finance shows that the short interest on Jan 31, 2024 was 3.41 million shares. A decline of -28.68% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.7 of the overall float, the days-to-cover ratio (short ratio) decline to 2.7.
